The observed incidence of adverse reactions in patients receiving omalizumab therapy in a tertiary allergy and asthma clinic in Canada

被引：0
|
作者：
Harrison, R. [1 ]
Santucci, S. [1 ]
MacRae, M. [1 ]
Yang, W. H. [1 ,2 ]
机构：
[1] Ottawa Allergy Res Corp, Ottawa, ON, Canada
[2] Univ Ottawa, Sch Med, Ottawa, ON K1N 6N5, Canada
来源：
ALLERGY | 2015年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
845
引用
收藏
页码：350 / 351
页数：2
相关论文
共 50 条
  • [31] Association of concurrent acid-suppression therapy with survival outcomes and adverse event incidence in oncology patients receiving erlotinib
    Lam, Lisa H.
    Capparelli, Edmund V.
    Kurzrock, Razelle
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 427 - 432
  • [32] INCIDENCE OF THROMBOEMBOLISM (TE) IN PATIENTS WITH MELANOMA RECEIVING IMMUNE CHECKPOINT INHIBITOR (ICI) THERAPY AND ITS ADVERSE IMPACT ON SURVIVAL
    Sussman, Tamara
    Roopkumar, Joanna
    Li, Hong
    McCrae, Keith
    Funchain, Pauline
    Khorana, Alok
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A390 - A391
  • [33] INCIDENCE AND PATTERN OF ADVERSE DRUG REACTIONS (ADRs) IN PATIENTS TREATED FOR TUBERCULOSIS UNDER DOTS AT A TERTIARY CARE HOSPITAL OF NORTHERN INDIA
    Tutu, Sachin
    Kant, Surya
    Verma, Ajay Kumar
    Sachan, Amod Kumar
    Nath, Rajendra
    Kumar, Narendra
    Singh, Arpita
    Dixit, Rakesh Kumar
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2018, 9 (11): : 4950 - 4955
  • [34] Sex differences in serious adverse drug reactions in patients receiving immunotherapy, targeted therapy, or chemotherapy: a disproportionality analysis of the VigiBase®
    Guillaume Wabont
    Sandrine Bergeron
    Sophie Gautier
    Romain Barus
    European Journal of Clinical Pharmacology, 2022, 78 : 1355 - 1356
  • [35] Sex differences in serious adverse drug reactions in patients receiving immunotherapy, targeted therapy, or chemotherapy: a disproportionality analysis of the VigiBase®
    Wabont, Guillaume
    Bergeron, Sandrine
    Gautier, Sophie
    Barus, Romain
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (08) : 1355 - 1356
  • [36] Monitoring of adverse drug reactions to antiretroviral drug therapy in aids patients in a tertiary care hospital - A prospective observational study
    Nagapal, M.
    Gupta, U.
    Kumar, S.
    INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 : 205 - 205
  • [37] ASSESSMENT OF QUALITY OF LIFE IN HUMAN IMMUNODEFIECIENCY VIRUS POSITIVE PATIENTS WITH ADVERSE REACTIONS TO ANTIRETROVIRAL THERAPY IN TERTIARY CARE HOSPITAL
    Aluri, R. K. C.
    VALUE IN HEALTH, 2014, 17 (07) : A807 - A808
  • [38] Effect of combined use of prednisone and immunosuppressive therapy in patients with systemic lupus erythematosus, and its influence on incidence of adverse reactions
    Liu, Juan
    Wang, Yunhong
    Wang, Xiaojun
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (06) : 1295 - 1300
  • [39] Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis
    Yu, Ya-Yen
    Tsao, Shih-Ming
    Yang, Wen-Ta
    Huang, Wei-Chang
    Lin, Ching-Hsiung
    Chen, Wei-Wen
    Yang, Shun-Fa
    Chiou, Hui-Ling
    Huang, Yi-Wen
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (01)
  • [40] Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia
    Kassa, Aragie
    Teka, Azmera
    Shewaamare, Aster
    Jerene, Degu
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2012, 106 (06) : 363 - 370
12345